THE MOST convincing method of demonstrating the presence of tumourspecific transplantation-type antigens (TSTAs) in the membrane of malignant cells is by inducing specific resistance to tumour grafts in syngeneic recipients by immunization. An effective way of producing immunity is to ligate or excise a growing tumour, but this procedure cannot be used for blood-borne leukaemias or if the tumours metastasize spontaneously. An alternative procedure by which immunity; has' been produced to many types of experimental tumours is by inoculation of intact tumour cells that have been rendered incapable of dividing, but which remain at least for a time, physiologically viable and maintain an intact membrane. " Sterilization " of tumour cells for immunization is usually achieved by exposing cells to x-rays although a number of cytotoxic agents have also proved effective. Using either technique, i.e. removal of a growing tumour or injection of " sterilized " cells most but not all-chemically and virally induced tumours could be shown to carry TSTAs capable of invoking immunity to challenge. On the other hand, there are several reports which show that it is frequently not possible to demonstrate resistance against tumours which have arisen spontaneously in pure line experimental animals (Prehn and Main, 1957; Baldwin, 1966) . This paper describes an investigation into the immunogenicity in vivo of the transplantable rat leukaemia referred to as SAL-which arose spontaneously in an August rat and which can be transplanted into syngeneic rats with as few as 10 cells (Wrathmell and Alexander, 1973; Wrathmell, 1976 Prager and Baechtel (1973) . For this study we used a cross-linking agent; glutaraldehyde, a sulphydryl blocking agent; sodium iodoacetate, and 2 antimitotic drugs: nitrogen mustard (Mustine) and mitomycin-C.
Both glutaraldehyde and sodium iodoacetate have been shown to improve the immunogenicity of tumour cells in other systems (Sanderson and Frost, 1974; Apffel, Arnason and Peters, 1966) . Mitomycin-C is used as an inhibitor of cell division in the mixed lymphocyte reaction in vitro, and nitrogen mustard has previously been employed to attenuate tumour cells for immunization purposes (Ishidate et al., 1965) .
MATERIALS AND METHODS
A ninmals and tumour used.-Pure line August rats were bred in the Institute's colony and used at 8-10 weeks of age. The Sutton August Leukaemia SAL (Wrathmell, 1976) was serially transplanted in syngeneic August rats using cells derived from the blood of leukaemic rats. SAL cells were obtained by centrifuging the blood from leukaemic rats at 500 g for 5 min and then resuspending the cells in medium 199. The SAL cells used for immunization were obtained from the spleens of leukaemic rats since large numbers of cells could be obtained in this way. The cells were washed and resuspended in TC 199.
Immunization procedure.-Rats were immunized at 4 subcutaneous sites and intraperitoneally with SAL cells suspended in 1.0 ml of TC 199, the number of cells injected being specified in the text. Two injections were given at 10-day intervals and t,he rats challenged 10 days after the second immunization.
Preparation of cells for immunization.-SAL spleen cells were washed and resuspended in TC 199 at a concentration of 5 x 107 cells/ml and then immediately x-irradiated at a dose rate of 800 rad/min from a 200 kV Marconi x-ray machine (no filter) at room temperature and under well oxygenated conditions. Cells were incubated with mitomycin-C (Dales Pharmaceuticals) The critical concentrations of mitomycin-C and SAL cells for sterilization were 5 ,ag/107 cells/ml and multiples of these concentrations, e.g. 0 5 ,ug/106 cells/ml or 50 jug/108 cells/ml. Figure 1 shows that only the minimum dose of mitomycin-C necessary for " sterilization " gave cells that were capable of protecting against an i.p. challenge with SAL cells. Optimally treated mitomycin-C SAL cells retain their protective action after extensive washing and this, as well as the dose dependence, shows that the protective effect cannot be attributed to a carry-over of mitomycin-C into the host. That this protection is specific is indicated by the fact that immunization with mitomycin-C treated normal August spleen cells does not render August rats more resistant to subsequent challenge with SAL (see Fig. 2 ). Cells killed by treatment with iodoacetate (Apffel et at., 1966; Wang and Halliday, 1966) , nitrogen mustard (Ishidate et al., 1965) or glutaraldehyde (Sanderson and Frost, 1974) have all been found to immunize syngeneic mice against a variety of tumours, and in some cases gave better protection than x-irradiated cells. SAL cells treated with these chemicals at the stated concentrations failed to immunize August rats against SAL cells (see Table) . Alexander (1974) has advanced the hypothesis that rapid spontaneous shedding of TSTAs results in (1) a high rate of metastatic spread, (2) inability of immunized animals to reject large inocula of tumour cells and (3) failure of cells exposed to x-rays to induce immunity. The rapidity with which SAL leukaemia disseminates is consistent with a tumour that has a high rate of TSTA shedding-unfortunately direct proof of this has not been obtained as we have been unable to grow SAL cells in vitro. A possible interpretation for the finding that SAL cells sterilized with low doses of mitomycin-C can induce weak resistance to challenge whereas those exposed to x-rays induce essentially no resistance at all, could be explained by the fact that x-rays interfere to a greater extent than does mitomycin-C with the new synthesis of TSTAs needed to replace those that are shed. Hence, cells sterilized with mitomycin-C will be more immunogenic than those sterilized by x-ray. It is known that at low doses mitomycin-C can prevent cell division by direct combination with DNA while leaving RNA and protein synthesis unaffected (Shatkin et al., 1962; Szybalski and Jyer, 1964) . It is interesting that Scollay, Lafferty and Poskitt (1974) found that lymphocytes lost their capacity to stimulate allogeneic cells in vitro after treatment with high, but not with low, concentrations of mitomycin-C. Whatever the mechanism responsible for the failure to immunize against SAL with x-irradiated cells, when detectable protection can be obtained with mitomycin-C treated cells, these experiments highlight the problem of deciding if any tumour does not have TSTAs.
